Bml Capital Management, LLC Aclaris Therapeutics, Inc. Transaction History
Bml Capital Management, LLC
- $161 Billion
- Q4 2024
A detailed history of Bml Capital Management, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 14,250,000 shares of ACRS stock, worth $32.8 Million. This represents 21.95% of its overall portfolio holdings.
Number of Shares
14,250,000
Previous 14,250,000
-0.0%
Holding current value
$32.8 Million
Previous $16.4 Billion
115.65%
% of portfolio
21.95%
Previous 9.64%
Shares
4 transactions
Others Institutions Holding ACRS
# of Institutions
106Shares Held
87.8MCall Options Held
293KPut Options Held
124K-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$22.1 Million0.04% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$20.4 Million4.3% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD6.2MShares$14.3 Million0.61% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.67MShares$10.7 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$9.95 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $153M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...